Real-world diagnostic outcomes and cost-effectiveness of genome-wide sequencing for developmental and seizure disorders: Evidence from Canada-Reference-Cited by-同舟云学术

Real-world diagnostic outcomes and cost-effectiveness of genome-wide sequencing for developmental and seizure disorders: Evidence from Canada

Published:2024-04 Issue:4 Volume:26 Page:101069
ISSN:1098-3600
Container-title:Genetics in Medicine
language:en
Short-container-title:Genetics in Medicine

Author:

Regier Dean A.,Loewen Rosalie,Chan Brandon,Ehman Morgan,Pollard Samantha,Friedman Jan M.,Stockler-Ipsiroglu Sylvia,van Karnebeek Clara,Race Simone,Elliott Alison M.,Dragojlovic Nick,Lynd Larry D.,Weymann Deirdre^ORCID

Funder

Genome British Columbia

Publisher

Elsevier BV

Reference46 articles.

1. Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases;Clark;NPJ Genom Med,2018

2. Systematic evidence-based review: outcomes from exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability;Malinowski;Genet Med,2020

3. Exome first approach to reduce diagnostic costs and time – retrospective analysis of 111 individuals with rare neurodevelopmental disorders;Klau;Eur J Hum Genet,2022

4. A cost-effectiveness analysis of genomic sequencing in a prospective versus historical cohort of complex pediatric patients;Yeung;Genet Med,2020

5. Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions;Lavelle;Genet Med,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Health Care Costs After Genome-Wide Sequencing for Children With Rare Diseases in England and Canada;JAMA Network Open;2024-07-10